These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30270337)

  • 1. [Low-dose perampanel improved cortical myoclonus and basophobia in a patient with Unverricht-Lundborg disease: a case report].
    Oi Y; Kobayashi K; Hitomi T; Matsumoto R; Ikeda A; Takahashi R
    Rinsho Shinkeigaku; 2018 Oct; 58(10):622-625. PubMed ID: 30270337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of the successful treatment of severe myoclonus with Lance-Adams syndrome by add-on perampanel showing long term effects].
    Saito K; Oi K; Inaba A; Kobayashi M; Ikeda A; Wada Y
    Rinsho Shinkeigaku; 2021 Jan; 61(1):18-23. PubMed ID: 33328418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perampanel in 12 patients with Unverricht-Lundborg disease.
    Crespel A; Gelisse P; Tang NP; Genton P
    Epilepsia; 2017 Apr; 58(4):543-547. PubMed ID: 28166365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked response to perampanel: A decade-long course of giant somatosensory evoked potentials in Unverricht-Lundborg disease.
    Tojima M; Takahashi R; Neshige S; Hitomi T; Matsuhashi M; Ikeda A
    Clin Neurophysiol; 2021 Oct; 132(10):2329-2331. PubMed ID: 34454258
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term efficacy of low-dose perampanel for progressive myoclonus epilepsy in a patient with Gaucher disease type 3.
    Tahara M; Higurashi N; Narita A; Ida H
    Brain Dev; 2022 Apr; 44(4):308-312. PubMed ID: 34991910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose perampanel improves refractory cortical myoclonus by the dispersed and suppressed paroxysmal depolarization shifts in the sensorimotor cortex.
    Oi K; Neshige S; Hitomi T; Kobayashi K; Tojima M; Matsuhashi M; Shimotake A; Fujii D; Matsumoto R; Kasama S; Kanda M; Wada Y; Maruyama H; Takahashi R; Ikeda A
    Clin Neurophysiol; 2019 Oct; 130(10):1804-1812. PubMed ID: 31401489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable course of Unverricht-Lundborg disease: Early prognostic factors.
    Canafoglia L; Ferlazzo E; Michelucci R; Striano P; Magaudda A; Gambardella A; Pasini E; Belcastro V; Riguzzi P; Fanella M; Granata T; Beccaria F; Trentini C; Bianchi A; Aguglia U; Panzica F; Franceschetti S
    Neurology; 2017 Oct; 89(16):1691-1697. PubMed ID: 28931642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
    Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
    J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type.
    Smith B; Shatz R; Elisevich K; Bespalova IN; Burmeister M
    Epilepsia; 2000 Aug; 41(8):1046-8. PubMed ID: 10961635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of motor cortical excitability and anatomy in Unverricht-Lundborg disease.
    Danner N; Julkunen P; Hyppönen J; Niskanen E; Säisänen L; Könönen M; Koskenkorva P; Vanninen R; Kälviäinen R; Mervaala E
    Mov Disord; 2013 Nov; 28(13):1860-7. PubMed ID: 23925991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease.
    Canafoglia L; Ciano C; Panzica F; Scaioli V; Zucca C; Agazzi P; Visani E; Avanzini G; Franceschetti S
    Neurology; 2004 Dec; 63(12):2309-15. PubMed ID: 15623692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement-related desynchronization-synchronization (ERD/ERS) in patients with Unverricht-Lundborg disease.
    Visani E; Agazzi P; Canafoglia L; Panzica F; Ciano C; Scaioli V; Avanzini G; Franceschetti S
    Neuroimage; 2006 Oct; 33(1):161-8. PubMed ID: 16904345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of cortical hyperexcitability in Japanese Unverricht-Lundborg disease.
    Kobayashi K; Hitomi T; Matsumoto R; Kondo T; Kawamata J; Matsuhashi M; Hashimoto S; Ikeda H; Koide Y; Inoue Y; Takahashi R; Ikeda A
    Seizure; 2014 Oct; 23(9):746-50. PubMed ID: 25023721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical and neurophysiological motor signature of Unverricht-Lundborg disease.
    Hainque E; Blancher A; Mesnage V; Rivaud-Pechoux S; Bertrand A; Dupont S; Navarro V; Roze E; Gourfinkel-An I; Apartis E
    Rev Neurol (Paris); 2018; 174(1-2):56-65. PubMed ID: 28688606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unverricht-Lundborg disease manifesting tremulous myoclonus with rare convulsive seizures: a case report].
    Kondo T; Yamakado H; Kawamata J; Tomimoto H; Hitomi T; Takahashi R; Ikeda A
    Rinsho Shinkeigaku; 2009 Jan; 49(1):43-7. PubMed ID: 19227896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
    Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Squillacote D; Yang H; Gee M; Zhu J; Laurenza A
    Epilepsia; 2013 Jan; 54(1):126-34. PubMed ID: 22905878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical sensorimotor alterations in Unverricht-Lundborg disease patients without generalized seizures.
    Silén T; Karjalainen T; Lehesjoki AE; Forss N
    Neurosci Lett; 2002 Apr; 323(2):101-4. PubMed ID: 11950503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
    Genton P; Gelisse P; Crespel A
    Epilepsia; 2006 Dec; 47(12):2083-5. PubMed ID: 17201707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.